Name:	isis_AssumedChangeInEstimatedSellingPriceOfProduct
Namespace Prefix:	isis_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Represents the average period for completion of an animal study or clinical trial.

No definition available.

Name:	isis_AverageDurationToCompletion
Namespace Prefix:	isis_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

The amount of change to the allocation of the consideration to a specific unit of accounting that would result from a specified change in the selling price factor applied to a multiple-deliverable arrangement.

No definition available.

Name:	isis_ChangeInAmountOfRevenueFromProductForAssumedChangeInSellingPrice
Namespace Prefix:	isis_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Revenue from arrangements that include licensing and royalty revenues, profit sharing and/or earn out payments. Licensing revenue represents revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements typically include, but are not limited to, rights to use intellectual property on an exclusive or non-exclusive basis. Royalty, profit sharing and/or earn out payments are derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's intellectual property.

No definition available.

Name:	isis_LicensingAndRoyaltyRevenue
Namespace Prefix:	isis_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the number of categories of milestone events.

No definition available.

Name:	isis_NumberOfCategoriesOfMilestoneEvents
Namespace Prefix:	isis_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of stages in the life-cycle of drugs, reflected in the categories of contractual milestones.

No definition available.

Name:	isis_NumberOfStagesOfLifeCycleOfDrugs
Namespace Prefix:	isis_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of active collaborations with the collaborative partner.

No definition available.

Name:	isis_NumberOfStrategicCollaborations
Namespace Prefix:	isis_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the number of targets for the research and development of drugs under a collaborative agreement.

No definition available.

Name:	isis_NumberOfTargetsForCollaborativeAgreement
Namespace Prefix:	isis_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

The percentage change to the allocation of the consideration to a specific unit of accounting that would result from a specified change in the selling price factor applied to a multiple-deliverable arrangement.

No definition available.

Name:	isis_PercentageChangeInAmountOfRevenueFromProductForAssumedChangeInSellingPrice
Namespace Prefix:	isis_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Represents the typical period within which approval is obtained once regulatory filings have been prepared and submitted.

No definition available.

Name:	isis_PeriodForObtainingRegulatoryApproval
Namespace Prefix:	isis_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the typical period within which regulatory filings are prepared and submitted.

No definition available.

Name:	isis_PeriodForPreparingAndSubmittingFilings
Namespace Prefix:	isis_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents a pre-specified sales threshold that could be used as a pre-specified event to trigger a milestone payment.

No definition available.

Name:	isis_PreSpecifiedSalesThreshold
Namespace Prefix:	isis_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents the number of separate units of accounting requiring the allocation of consideration for revenue recognition purposes under the multi-deliverable arrangement.

No definition available.

Name:	isis_RevenueRecognitionMultiDeliverableArrangementNumberOfUnitsOfAccounting
Namespace Prefix:	isis_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Represents the period for which the initial exclusive rights to the use of certain of the entity's technology is granted under the agreement.

No definition available.

Name:	isis_TermOfExclusiveRights
Namespace Prefix:	isis_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the amount of upfront fees received during the period under the agreement.

No definition available.

Name:	isis_UpfrontFeeReceived
Namespace Prefix:	isis_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

The portion of upfront fees received during the period under the terms of the agreement that are recognized as revenue during the period.

No definition available.

Name:	isis_UpfrontFeeRecognized
Namespace Prefix:	isis_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

No definition available.

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

Name:	us-gaap_DeferredRevenueAdditions
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Name:	us-gaap_TypeOfArrangementAxis=isis_CollaborativeArrangementsAndLicensingAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	isis_AchievementOfMilestoneAxis=isis_DevelopmentMilestonesNewDevelopmentCandidateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	isis_AchievementOfMilestoneAxis=isis_DevelopmentMilestonesPhaseOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	isis_AchievementOfMilestoneAxis=isis_DevelopmentMilestonesPhaseTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	isis_AchievementOfMilestoneAxis=isis_DevelopmentMilestonesPhaseThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	isis_AchievementOfMilestoneAxis=isis_RegulatoryMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	isis_AchievementOfMilestoneAxis=isis_CommercializationMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=isis_BayerHealthCareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=isis_AgreementEnteredIntoInMay2015Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=isis_IsisFxiMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=isis_IsisFxiDevelopmentServicesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=isis_IsisFxiActivePharmaceuticalIngredientMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CounterpartyNameAxis=isis_BiogenIdecMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=isis_CollaborativeArrangementJanuary2012Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=isis_IsisSmnMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=isis_CollaborativeArrangementJune2012Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=isis_IsisDmpkMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=isis_CollaborativeArrangementDecember2012Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=isis_NeurologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=isis_CollaborativeArrangementSeptember2013Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=isis_StrategicNeurologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: